There has been some confusion in the literature on the use of the term “M30”. Although it should be very clear that “M30” is a monoclonal antibody (“M”) that detects the antigen “ccK18”/“K18-Asp396” people sometimes refer to the antigen as “M30”. This is incorrect.   
It is clear that the use of the term “M30” in connection with “keratin” means the monoclonal antibody M30® or (possibly, but erroneously) the neo-epitope DALD396 on K18 recognized by the M30® monoclonal. “M30” is not a biological entity expressed in cells but a (patent protected) monoclonal antibody.
Caspase-cleaved fragment of keratin 18 = ccK18
Keratin 18 = K18 (or CK18)
M30® = the antibody that recognizes a neoepitope on ccK18
M65® ELISA = an ELISA composed of two antibodies (M5 and M6) for conventional epitopes of K18
M30®, Apoptosense®, M65®, EpiDeath®, and PEVIVA® are registered trademarks, including U.S. Trademarks 4,577,969, 2,749,204, 1,009,048, and 896,269. Additionally, VLVBio™ holds additional Trademarks in most countries worldwide.